Literature DB >> 12368252

An AscI boundary library for the studies of genetic and epigenetic alterations in CpG islands.

Zunyan Dai1, Dieter Weichenhan, Yue-Zhong Wu, Julia L Hall, Laura J Rush, Laura T Smith, Aparna Raval, Li Yu, Daniela Kroll, Joerg Muehlisch, Michael C Frühwald, Pieter de Jong, Joe Catanese, Ramana V Davuluri, Dominic J Smiraglia, Christoph Plass.   

Abstract

Knudson's two-hit hypothesis postulates that genetic alterations in both alleles are required for the inactivation of tumor-suppressor genes. Genetic alterations include small or large deletions and mutations. Over the past years, it has become clear that epigenetic alterations such as DNA methylation are additional mechanisms for gene silencing. Restriction Landmark Genomic Scanning (RLGS) is a two-dimensional gel electrophoresis that assesses the methylation status of thousands of CpG islands. RLGS has been applied successfully to scan cancer genomes for aberrant DNA methylation patterns. So far, the majority of this work was done using NotI as the restriction landmark site. Here, we describe the development of RLGS using AscI as the restriction landmark site for genome-wide scans of cancer genomes. The availability of AscI as a restriction landmark for RLGS allows for scanning almost twice as many CpG islands in the human genome compared with using NotI only. We describe the development of an AscI-EcoRV boundary library that supports the cloning of novel methylated genes. Feasibility of this system is shown in three tumor types, medulloblastomas, lung cancers, and head and neck cancers. We report the cloning of 178 AscI RLGS fragments via two methods by use of this library.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12368252      PMCID: PMC187524          DOI: 10.1101/gr.197402

Source DB:  PubMed          Journal:  Genome Res        ISSN: 1088-9051            Impact factor:   9.043


  29 in total

1.  Comprehensive cytogenetic and molecular genetic characterization of the TI-1 acute myeloid leukemia cell line reveals cross-contamination with K-562 cell line.

Authors:  Laura J Rush; Kristiina Heinonen; Krzysztof Mrózek; Brian J Wolf; Mohamed Abdel-Rahman; Jadwiga Szymanska; Paivi Peltomäki; Fehmida Kapadia; Clara D Bloomfield; Michael A Caligiuri; Christoph Plass
Journal:  Blood       Date:  2002-03-01       Impact factor: 22.113

2.  Combined restriction landmark genomic scanning and virtual genome scans identify a novel human homeobox gene, ALX3, that is hypermethylated in neuroblastoma.

Authors:  Katharina Wimmer; Xiao-xiang Zhu Xx; Jean Marie Rouillard; Peter F Ambros; Barbara J Lamb; Rork Kuick; Markus Eckart; Andreas Weinhäusl; Christa Fonatsch; Sam M Hanash
Journal:  Genes Chromosomes Cancer       Date:  2002-03       Impact factor: 5.006

Review 3.  Global and gene-specific methylation patterns in cancer: aspects of tumor biology and clinical potential.

Authors:  Michael C Frühwald; Christoph Plass
Journal:  Mol Genet Metab       Date:  2002-01       Impact factor: 4.797

4.  A comprehensive catalog of CpG islands methylated in human lung adenocarcinomas for the identification of tumor suppressor genes.

Authors:  Masahiko Shiraishi; Azumi Sekiguchi; Michael J Terry; Adam J Oates; Yuji Miyamoto; Ying H Chuu; Miyo Munakata; Takao Sekiya
Journal:  Oncogene       Date:  2002-05-23       Impact factor: 9.867

5.  HOX gene clusters are hotspots of de novo methylation in CpG islands of human lung adenocarcinomas.

Authors:  Masahiko Shiraishi; Azumi Sekiguchi; Adam J Oates; Michael J Terry; Yuji Miyamoto
Journal:  Oncogene       Date:  2002-05-16       Impact factor: 9.867

6.  Aberrant promoter methylation of previously unidentified target genes is a common abnormality in medulloblastomas--implications for tumor biology and potential clinical utility.

Authors:  M C Frühwald; M S O'Dorisio; Z Dai; S M Tanner; D A Balster; X Gao; F A Wright; C Plass
Journal:  Oncogene       Date:  2001-08-16       Impact factor: 9.867

7.  Global methylation profiling of lung cancer identifies novel methylated genes.

Authors:  Z Dai; R R Lakshmanan; W G Zhu; D J Smiraglia; L J Rush; M C Frühwald; R M Brena; B Li; F A Wright; P Ross; G A Otterson; C Plass
Journal:  Neoplasia       Date:  2001 Jul-Aug       Impact factor: 5.715

Review 8.  Methylation matters.

Authors:  J F Costello; C Plass
Journal:  J Med Genet       Date:  2001-05       Impact factor: 6.318

9.  Novel methylation targets in de novo acute myeloid leukemia with prevalence of chromosome 11 loci.

Authors:  L J Rush; Z Dai; D J Smiraglia; X Gao; F A Wright; M Frühwald; J F Costello; W A Held; L Yu; R Krahe; J E Kolitz; C D Bloomfield; M A Caligiuri; C Plass
Journal:  Blood       Date:  2001-05-15       Impact factor: 22.113

Review 10.  The study of aberrant methylation in cancer via restriction landmark genomic scanning.

Authors:  Dominic J Smiraglia; Christoph Plass
Journal:  Oncogene       Date:  2002-08-12       Impact factor: 9.867

View more
  6 in total

1.  Nicotine induced CpG methylation of Pax6 binding motif in StAR promoter reduces the gene expression and cortisol production.

Authors:  Tingting Wang; Man Chen; Lian Liu; Huaiyan Cheng; You-E Yan; Ying-Hong Feng; Hui Wang
Journal:  Toxicol Appl Pharmacol       Date:  2011-09-24       Impact factor: 4.219

Review 2.  Translating insights from the cancer genome into clinical practice.

Authors:  Lynda Chin; Joe W Gray
Journal:  Nature       Date:  2008-04-03       Impact factor: 49.962

3.  Aberrant DNA methylation of OLIG1, a novel prognostic factor in non-small cell lung cancer.

Authors:  Romulo M Brena; Carl Morrison; Sandya Liyanarachchi; David Jarjoura; Ramana V Davuluri; Gregory A Otterson; David Reisman; Selina Glaros; Laura J Rush; Christoph Plass
Journal:  PLoS Med       Date:  2007-03-27       Impact factor: 11.069

4.  NOGOB receptor deficiency increases cerebrovascular permeability and hemorrhage via impairing histone acetylation-mediated CCM1/2 expression.

Authors:  Zhi Fang; Xiaoran Sun; Xiang Wang; Ji Ma; Thomas Palaia; Ujala Rana; Benjamin Miao; Louis Ragolia; Wenquan Hu; Qing Robert Miao
Journal:  J Clin Invest       Date:  2022-05-02       Impact factor: 19.456

5.  Epigenetic repression of the dopamine receptor D4 in pediatric tumors of the central nervous system.

Authors:  Rebekka Unland; Kornelius Kerl; Sabrina Schlosser; Nicole Farwick; Tanja Plagemann; Birigit Lechtape; Steven C Clifford; Jonas H Kreth; Joachim Gerss; Jörg Mühlisch; Günther H S Richter; Martin Hasselblatt; Michael C Frühwald
Journal:  J Neurooncol       Date:  2013-11-22       Impact factor: 4.130

6.  Restriction landmark genomic scanning (RLGS) spot identification by second generation virtual RLGS in multiple genomes with multiple enzyme combinations.

Authors:  Dominic J Smiraglia; Ramakrishnan Kazhiyur-Mannar; Christopher C Oakes; Yue-Zhong Wu; Ping Liang; Tahmina Ansari; Jian Su; Laura J Rush; Laura T Smith; Li Yu; Chunhui Liu; Zunyan Dai; Shih-Shih Chen; Shu-Huei Wang; Joseph Costello; Ilya Ioshikhes; David W Dawson; Jason S Hong; Michael A Teitell; Angela Szafranek; Marta Camoriano; Fei Song; Rosemary Elliott; William Held; Jacquetta M Trasler; Christoph Plass; Rephael Wenger
Journal:  BMC Genomics       Date:  2007-11-30       Impact factor: 3.969

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.